StockData
Clene Inc. logo

Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.22−0.44 (-12.02%)

Close on Nov 17, 2026Market cap $41.37MP/E –Yield –

Clene operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Clene's operating cash flow for the twelve months ending Jun 30, 2026 was -$15.91M. For fiscal 2025 it was -$18.55M. The highest annual figure on record is -$13.20M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$18.55M–
FY2024Dec 31, 2024-$21.33M–
FY2023Dec 31, 2023-$30.17M–
FY2022Dec 31, 2022-$39.01M–
FY2021Dec 31, 2021-$34.62M–
FY2020Dec 31, 2020-$18.93M–
FY2019Dec 31, 2019-$13.20M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.59M–
Q1 FY2026Mar 31, 2026-$4.53M–
Q4 FY2025Dec 31, 2025-$4.80M–
Q3 FY2025Sep 30, 2025-$3.99M–
Q2 FY2025Jun 30, 2025-$4.74M–
Q1 FY2025Mar 31, 2025-$5.01M–
Q4 FY2024Dec 31, 2024-$4.87M–
Q3 FY2024Sep 30, 2024-$3.02M–
Q2 FY2024Jun 30, 2024-$6.36M–
Q1 FY2024Mar 31, 2024-$7.08M–
Q4 FY2023Dec 31, 2023-$7.17M–
Q3 FY2023Sep 30, 2023-$6.76M–
Q2 FY2023Jun 30, 2023-$7.02M–
Q1 FY2023Mar 31, 2023-$9.22M–
Q2 FY2022Jun 30, 2022-$9.73M–
Q1 FY2022Mar 31, 2022-$13.08M–
Q4 FY2021Dec 31, 2021-$9.61M–
Q3 FY2021Sep 30, 2021-$7.31M–
Q2 FY2021Jun 30, 2021-$8.55M–
Q1 FY2021Mar 31, 2021-$9.16M–
Q4 FY2020Dec 31, 2020-$5.81M–
Q3 FY2020Sep 30, 2020-$7.72M–
Q2 FY2020Jun 30, 2020-$2.15M–
Q1 FY2020Mar 31, 2020-$3.25M–

More Clene figures

See a number that looks wrong?